These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20415594)

  • 1. Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target.
    Luo G; Ibrahim AS; Spellberg B; Nobile CJ; Mitchell AP; Fu Y
    J Infect Dis; 2010 Jun; 201(11):1718-28. PubMed ID: 20415594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.
    Luo G; Ibrahim AS; French SW; Edwards JE; Fu Y
    PLoS One; 2011; 6(10):e25909. PubMed ID: 22028796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
    Uppuluri P; Lin L; Alqarihi A; Luo G; Youssef EG; Alkhazraji S; Yount NY; Ibrahim BA; Bolaris MA; Edwards JE; Swidergall M; Filler SG; Yeaman MR; Ibrahim AS
    PLoS Pathog; 2018 May; 14(5):e1007056. PubMed ID: 29746596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the function of Candida albicans Als3 by heterologous expression in Candida glabrata.
    Fu Y; Phan QT; Luo G; Solis NV; Liu Y; Cormack BP; Edwards JE; Ibrahim AS; Filler SG
    Infect Immun; 2013 Jul; 81(7):2528-35. PubMed ID: 23630968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies targeting
    Singh S; Nabeela S; Barbarino A; Ibrahim AS; Uppuluri P
    Front Immunol; 2022; 13():925821. PubMed ID: 35935947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moonlighting proteins induce protection in a mouse model against Candida species.
    Medrano-Díaz CL; Vega-González A; Ruiz-Baca E; Moreno A; Cuéllar-Cruz M
    Microb Pathog; 2018 Nov; 124():21-29. PubMed ID: 30118801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Bcr1-activated genes Hwp1 and Hyr1 in Candida albicans oral mucosal biofilms and neutrophil evasion.
    Dwivedi P; Thompson A; Xie Z; Kashleva H; Ganguly S; Mitchell AP; Dongari-Bagtzoglou A
    PLoS One; 2011 Jan; 6(1):e16218. PubMed ID: 21283544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
    Shukla M; Rohatgi S
    Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Post-Vaccination Phagocytic Activation Using Candida albicans Killing Assays.
    Li W; Hu Y
    Methods Mol Biol; 2017; 1625():313-326. PubMed ID: 28584999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of innate immune response to Candida albicans infections by αMβ2-Pra1p interaction.
    Soloviev DA; Jawhara S; Fonzi WA
    Infect Immun; 2011 Apr; 79(4):1546-58. PubMed ID: 21245270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal IgM Antibodies Targeting
    Youssef EG; Zhang L; Alkhazraji S; Gebremariam T; Singh S; Yount NY; Yeaman MR; Uppuluri P; Ibrahim AS
    Front Immunol; 2020; 11():76. PubMed ID: 32153560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis.
    Rane HS; Hardison S; Botelho C; Bernardo SM; Wormley F; Lee SA
    Virulence; 2014; 5(8):810-8. PubMed ID: 25483774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans.
    Fu Y; Luo G; Spellberg BJ; Edwards JE; Ibrahim AS
    Eukaryot Cell; 2008 Mar; 7(3):483-92. PubMed ID: 18178776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
    Cutler JE; Corti M; Lambert P; Ferris M; Xin H
    PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the GPI protein-encoding gene IFF4 of Candida albicans results in decreased adherence and virulence.
    Kempf M; Cottin J; Licznar P; Lefrançois C; Robert R; Apaire-Marchais V
    Mycopathologia; 2009 Aug; 168(2):73-7. PubMed ID: 19347602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
    Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
    Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with Recombinant Non-transmembrane Domain of Protein Mannosyltransferase 4 Improves Survival during Murine Disseminated Candidiasis.
    Wang L; Yan L; Li XX; Xu GT; An MM; Jiang YY
    Biol Pharm Bull; 2015; 38(11):1779-87. PubMed ID: 26268065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of antigen delivery using monoolein-based liposomes in experimental hematogenously disseminated candidiasis.
    Carneiro C; Correia A; Lima T; Vilanova M; Pais C; Gomes AC; Real Oliveira MECD; Sampaio P
    Acta Biomater; 2016 Jul; 39():133-145. PubMed ID: 27150234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.